We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tiny Robots Could Speed Targeted Drug Delivery to Heart Infections

By HospiMedica International staff writers
Posted on 13 Oct 2026

Endocarditis is an infection of heart tissue that can become life-threatening when treatment fails to reach the infected site. More...

About 50,000 people in the United States develop the condition each year. Standard intravenous antibiotics may be diluted before reaching the heart, while open-heart surgery carries major risk. To improve local treatment delivery, researchers have developed wireless millirobots intended to deliver antibiotics directly to infected tissue inside a beating heart.

Engineers at Johns Hopkins University created the magnetically powered robots, which are about as wide as a pencil tip or matchstick head and about as long as a grain of rice. The devices are designed to travel through the body after insertion through a small puncture, providing a potential less invasive alternative to prolonged intravenous drug therapy or open-heart surgery.

The system uses two robots that work together. A needle module gently attaches to heart tissue at the infected site and acts as a docking station. A drug module then carries antibiotics to that location, docks magnetically with the needle module, and slowly releases medication where it is needed.

Both modules are magnetic and are guided wirelessly by an external electromagnetic coil system. The system works in a manner similar to MRI technology, but it drives the robots rather than creating images. Separating the device into two smaller robots allows the system to reach confined anatomy, while the docked needle module can remain in place for repeat dosing.

The work was published in Advanced Material Technologies on September 28, 2026. The robots were tested on phantom heart models that closely mimic a human heart and on real porcine heart tissue. In those tests, the robots traveled smoothly and autonomously, including against simulated blood flow.

The researchers also reported that robot-based drug delivery could potentially shorten treatment time from weeks to hours. They further noted that the same targeted approach could be useful for delivering medications to sites of cancer spread. The next step is to test the robots in more realistic phantom hearts that include muscle contraction and beating motion.

“With just a little pinprick, you insert a micro robot and do a procedure without infection or blood loss. And you don’t need to have a surgeon operating it to get the drugs robustly, safely and efficiently to the right place. There's a lot of areas beyond heart infections where this kind of targeted drug therapy and these kinds of steerable robots could play a major role. It’s really the frontier of surgical robotics,” said Axel Krieger, senior author and medical roboticist at Johns Hopkins University.

Related Links
Johns Hopkins University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Tourniquet System
heidi– mein Tourniquet
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The proposed sensor incorporates two ion-selective electrodes and a liquid-junction reference electrode, which allows the device to operate without the need for long pre-adjustment periods. (Photo courtesy of Associate Professor Isao Shitanda from Tokyo University of Science, Japan)

Wristwatch Sensor Tracks Sodium and Potassium in Sweat in Real Time

Sweat can provide real-time biochemical information about the body’s physiological state, with sodium and potassium measurements offering potential value for monitoring people working or exercising in... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.